LINDA GOLDEN: Open Payments
NPI 1578735692 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 26 payments from 7 companies in 2025. Trend: 2023 $405 · 2024 $504 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $251 |
| Novo Nordisk Inc | 7 | $146 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $90 |
| Currax Pharmaceuticals LLC | 3 | $49 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Ethicon US, LLC | 1 | $20 |
| Boston Scientific Corporation | 1 | $17 |
Products named: ZEPBOUND, Wegovy, JOURNAVX, CONTRAVE, MOUNJARO, Exparel, Echelon Flex, SpyGlass Discover.
Industry payments across TX — which companies pay providers there.
